BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 29269116)

  • 1. Epigenetic regulation in medulloblastoma.
    Yi J; Wu J
    Mol Cell Neurosci; 2018 Mar; 87():65-76. PubMed ID: 29269116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transitioning from genotypes to epigenotypes: why the time has come for medulloblastoma epigenomics.
    Batora NV; Sturm D; Jones DT; Kool M; Pfister SM; Northcott PA
    Neuroscience; 2014 Apr; 264():171-85. PubMed ID: 23876321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SMARCA4/Brg1 coordinates genetic and epigenetic networks underlying Shh-type medulloblastoma development.
    Shi X; Wang Q; Gu J; Xuan Z; Wu JI
    Oncogene; 2016 Nov; 35(44):5746-5758. PubMed ID: 27065321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenetic Drivers in Pediatric Medulloblastoma.
    Roussel MF; Stripay JL
    Cerebellum; 2018 Feb; 17(1):28-36. PubMed ID: 29178021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetic deregulation of multiple S100 gene family members by differential hypomethylation and hypermethylation events in medulloblastoma.
    Lindsey JC; Lusher ME; Anderton JA; Gilbertson RJ; Ellison DW; Clifford SC
    Br J Cancer; 2007 Jul; 97(2):267-74. PubMed ID: 17579622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetic regulation in medulloblastoma pathogenesis revealed by genetically engineered mouse models.
    Shiraishi R; Kawauchi D
    Cancer Sci; 2021 Aug; 112(8):2948-2957. PubMed ID: 34050694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetic events in medulloblastoma development.
    Lindsey JC; Anderton JA; Lusher ME; Clifford SC
    Neurosurg Focus; 2005 Nov; 19(5):E10. PubMed ID: 16398460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medulloblastoma: Molecular understanding, treatment evolution, and new developments.
    Liu X; Ding C; Tan W; Zhang A
    Pharmacol Ther; 2020 Jun; 210():107516. PubMed ID: 32105673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SnapShot: Medulloblastoma.
    Rusert JM; Wu X; Eberhart CG; Taylor MD; Wechsler-Reya RJ
    Cancer Cell; 2014 Dec; 26(6):940-940.e1. PubMed ID: 25490452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decoding the regulatory landscape of medulloblastoma using DNA methylation sequencing.
    Hovestadt V; Jones DT; Picelli S; Wang W; Kool M; Northcott PA; Sultan M; Stachurski K; Ryzhova M; Warnatz HJ; Ralser M; Brun S; Bunt J; Jäger N; Kleinheinz K; Erkek S; Weber UD; Bartholomae CC; von Kalle C; Lawerenz C; Eils J; Koster J; Versteeg R; Milde T; Witt O; Schmidt S; Wolf S; Pietsch T; Rutkowski S; Scheurlen W; Taylor MD; Brors B; Felsberg J; Reifenberger G; Borkhardt A; Lehrach H; Wechsler-Reya RJ; Eils R; Yaspo ML; Landgraf P; Korshunov A; Zapatka M; Radlwimmer B; Pfister SM; Lichter P
    Nature; 2014 Jun; 510(7506):537-41. PubMed ID: 24847876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Active medulloblastoma enhancers reveal subgroup-specific cellular origins.
    Lin CY; Erkek S; Tong Y; Yin L; Federation AJ; Zapatka M; Haldipur P; Kawauchi D; Risch T; Warnatz HJ; Worst BC; Ju B; Orr BA; Zeid R; Polaski DR; Segura-Wang M; Waszak SM; Jones DT; Kool M; Hovestadt V; Buchhalter I; Sieber L; Johann P; Chavez L; Gröschel S; Ryzhova M; Korshunov A; Chen W; Chizhikov VV; Millen KJ; Amstislavskiy V; Lehrach H; Yaspo ML; Eils R; Lichter P; Korbel JO; Pfister SM; Bradner JE; Northcott PA
    Nature; 2016 Feb; 530(7588):57-62. PubMed ID: 26814967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medulloblastoma epigenetics and the path to clinical innovation.
    Haltom AR; Toll SA; Cheng D; Maegawa S; Gopalakrishnan V; Khatua S
    J Neurooncol; 2020 Oct; 150(1):35-46. PubMed ID: 32816225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [miR-449a is a potential epigenetic biomarker for WNT subtype of medulloblastoma].
    Li YX; Shao LW; Jiang T; Liu Y; Chang Q
    Zhonghua Bing Li Xue Za Zhi; 2017 Oct; 46(10):684-689. PubMed ID: 29050069
    [No Abstract]   [Full Text] [Related]  

  • 14. Medulloblastoma biology in the post-genomic era.
    Archer TC; Pomeroy SL
    Future Oncol; 2012 Dec; 8(12):1597-604. PubMed ID: 23231521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. OTX2 Activity at Distal Regulatory Elements Shapes the Chromatin Landscape of Group 3 Medulloblastoma.
    Boulay G; Awad ME; Riggi N; Archer TC; Iyer S; Boonseng WE; Rossetti NE; Naigles B; Rengarajan S; Volorio A; Kim JC; Mesirov JP; Tamayo P; Pomeroy SL; Aryee MJ; Rivera MN
    Cancer Discov; 2017 Mar; 7(3):288-301. PubMed ID: 28213356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A molecular fingerprint for medulloblastoma.
    Lee Y; Miller HL; Jensen P; Hernan R; Connelly M; Wetmore C; Zindy F; Roussel MF; Curran T; Gilbertson RJ; McKinnon PJ
    Cancer Res; 2003 Sep; 63(17):5428-37. PubMed ID: 14500378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic-Based Therapy-A Prospective Chance for Medulloblastoma Patients' Recovery.
    Strejczek A; Woszczyk D; Urbaniak H; Różańska M; Robak M; Matuszewska Z; Barciszewska AM
    Int J Mol Sci; 2021 May; 22(9):. PubMed ID: 34066495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel mutations target distinct subgroups of medulloblastoma.
    Robinson G; Parker M; Kranenburg TA; Lu C; Chen X; Ding L; Phoenix TN; Hedlund E; Wei L; Zhu X; Chalhoub N; Baker SJ; Huether R; Kriwacki R; Curley N; Thiruvenkatam R; Wang J; Wu G; Rusch M; Hong X; Becksfort J; Gupta P; Ma J; Easton J; Vadodaria B; Onar-Thomas A; Lin T; Li S; Pounds S; Paugh S; Zhao D; Kawauchi D; Roussel MF; Finkelstein D; Ellison DW; Lau CC; Bouffet E; Hassall T; Gururangan S; Cohn R; Fulton RS; Fulton LL; Dooling DJ; Ochoa K; Gajjar A; Mardis ER; Wilson RK; Downing JR; Zhang J; Gilbertson RJ
    Nature; 2012 Aug; 488(7409):43-8. PubMed ID: 22722829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic and epigenetic inactivation of Kruppel-like factor 4 in medulloblastoma.
    Nakahara Y; Northcott PA; Li M; Kongkham PN; Smith C; Yan H; Croul S; Ra YS; Eberhart C; Huang A; Bigner D; Grajkowska W; Van Meter T; Rutka JT; Taylor MD
    Neoplasia; 2010 Jan; 12(1):20-7. PubMed ID: 20072650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BarTeL, a Genetically Versatile, Bioluminescent and Granule Neuron Precursor-Targeted Mouse Model for Medulloblastoma.
    Shackleford GM; Shi XH; Swanson KS; Mahdi MY; Gonzalez-Gomez I; Asgharzadeh S; D'Apuzzo M; Erdreich-Epstein A; Moats RA
    PLoS One; 2016; 11(6):e0156907. PubMed ID: 27310018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.